Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuela Albisetti

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 4, 2026
Clinical Outcomes of Efanesoctocog Alfa Prophylaxis in Children With Severe Haemophilia A: Interim Data From XTEND-edLynn Malec, Beatrice Nolan, Anthony K C Chan, et al.
Thrombosis and Haemostasis|December 5, 2017
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate Oral Liquid Formulation in Infants with Venous ThromboembolismJacqueline M L Halton, Anne-Caroline Picard, Ruth Harper, et al.
Journal of Thrombosis and Haemostasis : JTH|November 11, 2020
Consensus-based clinical recommendations and research priorities for anticoagulant thromboprophylaxis in children hospitalized for COVID-19-related illnessNeil A Goldenberg, Anthony Sochet, Manuela Albisetti, et al.
Journal of Thrombosis and Haemostasis : JTH|January 11, 2025
Systematic analysis of the design, methodology, and patient population characteristics of the pediatric direct oral anticoagulant trials of venous thromboembolism treatmentMarisol Betensky, Manuela Albisetti, Tina Biss, et al.
Journal of Thrombosis and Haemostasis : JTH|February 26, 2021
Pharmacokinetic modeling and simulation support for age- and weight-adjusted dosing of dabigatran etexilate in children with venous thromboembolismDaniel Röshammar, Fenglei Huang, Manuela Albisetti, et al.
Research and Practice in Thrombosis and Haemostasis|July 27, 2018
Design and rationale for the DIVERSITY study: An open-label, randomized study of dabigatran etexilate for pediatric venous thromboembolismManuela Albisetti, Branislav Biss, Lisa Bomgaars, et al.
Research and Practice in Thrombosis and Haemostasis|July 27, 2018
Phase 3, single-arm, multicenter study of dabigatran etexilate for secondary prevention of venous thromboembolism in children: Rationale and designMatteo Luciani, Manuela Albisetti, Branislav Biss, et al.
Journal of Thrombosis and Haemostasis : JTH|April 1, 2021
International pediatric thrombosis network to advance pediatric thrombosis research: Communication from the ISTH SSC subcommittee on pediatric and neonatal thrombosis and hemostasisC Heleen van Ommen, Manuela Albisetti, Mohir Bhatt, et al.
Swiss Medical Weekly|December 18, 2020
Management of bleeding events and invasive procedures in patients with haemophilia A without inhibitors treated with emicizumabPierre Fontana, Lorenzo Alberio, Manuela Albisetti, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 26, 2025
Five-Year Experience of Haemophilia Centre Certification Performed by the German, Austrian and Swiss Society for Thrombosis and Haemostasis ResearchHermann Eichler, Hagen Bönigk, Susan Halimeh, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 4, 2026
Clinical Outcomes of Efanesoctocog Alfa Prophylaxis in Children With Severe Haemophilia A: Interim Data From XTEND-edLynn Malec, Beatrice Nolan, Anthony K C Chan, et al.
Thrombosis and Haemostasis|December 5, 2017
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate Oral Liquid Formulation in Infants with Venous ThromboembolismJacqueline M L Halton, Anne-Caroline Picard, Ruth Harper, et al.
Journal of Thrombosis and Haemostasis : JTH|November 11, 2020
Consensus-based clinical recommendations and research priorities for anticoagulant thromboprophylaxis in children hospitalized for COVID-19-related illnessNeil A Goldenberg, Anthony Sochet, Manuela Albisetti, et al.
Journal of Thrombosis and Haemostasis : JTH|January 11, 2025
Systematic analysis of the design, methodology, and patient population characteristics of the pediatric direct oral anticoagulant trials of venous thromboembolism treatmentMarisol Betensky, Manuela Albisetti, Tina Biss, et al.
Journal of Thrombosis and Haemostasis : JTH|February 26, 2021
Pharmacokinetic modeling and simulation support for age- and weight-adjusted dosing of dabigatran etexilate in children with venous thromboembolismDaniel Röshammar, Fenglei Huang, Manuela Albisetti, et al.
Research and Practice in Thrombosis and Haemostasis|July 27, 2018
Design and rationale for the DIVERSITY study: An open-label, randomized study of dabigatran etexilate for pediatric venous thromboembolismManuela Albisetti, Branislav Biss, Lisa Bomgaars, et al.
Research and Practice in Thrombosis and Haemostasis|July 27, 2018
Phase 3, single-arm, multicenter study of dabigatran etexilate for secondary prevention of venous thromboembolism in children: Rationale and designMatteo Luciani, Manuela Albisetti, Branislav Biss, et al.
Journal of Thrombosis and Haemostasis : JTH|April 1, 2021
International pediatric thrombosis network to advance pediatric thrombosis research: Communication from the ISTH SSC subcommittee on pediatric and neonatal thrombosis and hemostasisC Heleen van Ommen, Manuela Albisetti, Mohir Bhatt, et al.
Swiss Medical Weekly|December 18, 2020
Management of bleeding events and invasive procedures in patients with haemophilia A without inhibitors treated with emicizumabPierre Fontana, Lorenzo Alberio, Manuela Albisetti, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 26, 2025
Five-Year Experience of Haemophilia Centre Certification Performed by the German, Austrian and Swiss Society for Thrombosis and Haemostasis ResearchHermann Eichler, Hagen Bönigk, Susan Halimeh, et al.
Pageof 8